位置:首页 > 蛋白库 > CAS3_STRTR
CAS3_STRTR
ID   CAS3_STRTR              Reviewed;         926 AA.
AC   F2XG53;
DT   13-JUN-2012, integrated into UniProtKB/Swiss-Prot.
DT   31-MAY-2011, sequence version 1.
DT   03-AUG-2022, entry version 50.
DE   RecName: Full=CRISPR-associated nuclease/helicase Cas3;
DE            EC=3.1.-.-;
DE            EC=3.6.4.-;
GN   Name=cas3;
OS   Streptococcus thermophilus.
OC   Bacteria; Firmicutes; Bacilli; Lactobacillales; Streptococcaceae;
OC   Streptococcus.
OX   NCBI_TaxID=1308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION AS AN ATPASE, FUNCTION AS A
RP   NUCLEASE, FUNCTION AS A HELICASE, ACTIVITY REGULATION, AND MUTAGENESIS OF
RP   ASP-77; ASP-227; GLN-290; LYS-316; ASP-452; GLU-453; ARG-663 AND ARG-666.
RC   STRAIN=DGCC7710;
RX   PubMed=21343909; DOI=10.1038/emboj.2011.41;
RA   Sinkunas T., Gasiunas G., Fremaux C., Barrangou R., Horvath P., Siksnys V.;
RT   "Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the
RT   CRISPR/Cas immune system.";
RL   EMBO J. 30:1335-1342(2011).
CC   -!- FUNCTION: CRISPR (clustered regularly interspaced short palindromic
CC       repeat), is an adaptive immune system that provides protection against
CC       mobile genetic elements (viruses, transposable elements and conjugative
CC       plasmids). CRISPR clusters contain sequences complementary to
CC       antecedent mobile elements and target invading nucleic acids. CRISPR
CC       clusters are transcribed and processed into CRISPR RNA (crRNA). Cas3
CC       plus Cascade participate in CRISPR interference, the third stage of
CC       CRISPR immunity. Functions as a ssDNA-dependent ATPase; dsDNA, ssRNA do
CC       not stimulate ATPase activity, while other nucleotides (aside from
CC       dATP) are not hydrolyzed. Functions as a ssDNA nuclease; activity does
CC       not require ATP. Functions as an ATP-dependent helicase; helicase
CC       activity requires hydrolysable ATP. Unwinds both DNA/DNA hybrids and
CC       RNA/DNA hybrids, moving mostly in a 3' to 5' direction.
CC       {ECO:0000269|PubMed:21343909}.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC       Note=Mn(2+) or Mg(2+) or Ca(2+). ATPase and nuclease activities are
CC       dependent on divalent cations, for ATPase Mn(2+) is marginally
CC       preferred over Mg(2+) or Ca(2+).;
CC   -!- ACTIVITY REGULATION: Nuclease activity is inhibited by EDTA.
CC       {ECO:0000269|PubMed:21343909}.
CC   -!- DOMAIN: Proteins of this family have an N-terminal nuclease domain and
CC       a C-terminal helicase/ATPase domain. In some CRISPR/Cas systems the
CC       domains are swapped, in others they are encoded separately.
CC   -!- MISCELLANEOUS: Found in the E.coli-type CRISPR4/cas system.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the CRISPR-associated
CC       nuclease Cas3-HD family. {ECO:0000305}.
CC   -!- SIMILARITY: In the central section; belongs to the CRISPR-associated
CC       helicase Cas3 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; HQ453272; ADV90802.1; -; Genomic_DNA.
DR   RefSeq; WP_037623090.1; NZ_QFLC01000003.1.
DR   AlphaFoldDB; F2XG53; -.
DR   SMR; F2XG53; -.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004536; F:deoxyribonuclease activity; IDA:CACAO.
DR   GO; GO:0004386; F:helicase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.3210.30; -; 1.
DR   Gene3D; 3.40.50.300; -; 2.
DR   InterPro; IPR035011; Cas3.
DR   InterPro; IPR041372; Cas3_C.
DR   InterPro; IPR006483; CRISPR-assoc_Cas3_HD.
DR   InterPro; IPR038257; CRISPR-assoc_Cas3_HD_sf.
DR   InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR006474; Helicase_Cas3_CRISPR-ass_core.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR47959:SF5; PTHR47959:SF5; 1.
DR   Pfam; PF18395; Cas3_C; 1.
DR   Pfam; PF00270; DEAD; 1.
DR   Pfam; PF18019; HD_6; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR01587; cas3_core; 1.
DR   TIGRFAMs; TIGR01596; cas3_HD; 1.
DR   PROSITE; PS51643; HD_CAS3; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
PE   1: Evidence at protein level;
KW   Antiviral defense; ATP-binding; Helicase; Hydrolase; Magnesium;
KW   Metal-binding; Nuclease; Nucleotide-binding.
FT   CHAIN           1..926
FT                   /note="CRISPR-associated nuclease/helicase Cas3"
FT                   /id="PRO_0000417607"
FT   DOMAIN          17..229
FT                   /note="HD Cas3-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00974"
FT   DOMAIN          297..504
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   DOMAIN          551..745
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00542"
FT   MOTIF           452..455
FT                   /note="DEAH box"
FT   BINDING         77
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         150
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         310..317
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   MUTAGEN         77
FT                   /note="D->A: Loss of ssDNA nuclease activity, no effect on
FT                   helicase activity."
FT                   /evidence="ECO:0000269|PubMed:21343909"
FT   MUTAGEN         227
FT                   /note="D->A: Loss of ssDNA nuclease activity."
FT                   /evidence="ECO:0000269|PubMed:21343909"
FT   MUTAGEN         290
FT                   /note="Q->A: Loss of ssDNA-dependent ATPase."
FT                   /evidence="ECO:0000269|PubMed:21343909"
FT   MUTAGEN         316
FT                   /note="K->A: Loss of ssDNA-dependent ATPase."
FT                   /evidence="ECO:0000269|PubMed:21343909"
FT   MUTAGEN         452
FT                   /note="D->A: Loss of ssDNA-dependent ATPase, loss of
FT                   helicase activity."
FT                   /evidence="ECO:0000269|PubMed:21343909"
FT   MUTAGEN         453
FT                   /note="E->A: Loss of ssDNA-dependent ATPase."
FT                   /evidence="ECO:0000269|PubMed:21343909"
FT   MUTAGEN         663
FT                   /note="R->A: Loss of ssDNA-dependent ATPase."
FT                   /evidence="ECO:0000269|PubMed:21343909"
FT   MUTAGEN         666
FT                   /note="R->A: Loss of ssDNA-dependent ATPase."
FT                   /evidence="ECO:0000269|PubMed:21343909"
SQ   SEQUENCE   926 AA;  105760 MW;  CFBD0C7E1300FEF3 CRC64;
     MKHINDYFWA KKTEENSRLL WLPLTQHLED TKNIAGLLWE HWLSEGQKVL IENSINVKSN
     IENQGKRLAQ FLGAVHDIGK ATPAFQTQKG YANSVDLDIQ LLEKLERAGF SGISSLQLAS
     PKKSHHSIAG QYLLSHYGVD EDIATIIGGH HGRPVDDLDG LNSQKSYPSN YYQDEKKDSL
     VYQKWKSNQE AFLNWALTET GFNSVSQLPK IKQPAQVILS GLLIMSDWIA SNEHFFPLLS
     LDETDVKNKS QRIETGFKKW KKSNLWQPET FVDLVTLYQE RFGFSPRNFQ LILSQTIEKT
     TNPGIVILEA PMGIGKTEAA LAVSEQLSSK KGCSGLFFGL PTQATSNGIF KRIEQWTENI
     KGNNSDHFSI QLVHGKAALN TDFIELLKGN TINMDDSENG SIFVNEWFSG RKTSALDDFV
     VGTVDQFLMV ALKQKHLALR HLGFSKKVIV IDEVHAYDAY MSQYLLEAIR WMGAYGVPVI
     ILSATLPAQQ REKLIKSYMA GMGVKWRDIE NIDQIKIDAY PLITYNDGPD IHQVKMFEKQ
     EQKNIYIHRL PEEQLFDIVK EGLDNGGVVG IIVNTVRKSQ ELARNFSDIF GDDMVDLLHS
     NFIATERIRK EKDLLQEIGK KAIRPPKKII IGTQVLEQSL DIDFDVLISD LAPMDLLIQR
     IGRLHRHKIK RPQKHEVARF YVLGTFEEFD FDEGTRLVYG DYLLARTQYF LPDKIRLPDD
     ISPLVQKVYN SDLTITFPKP ELHKKYLDAK IEHDDKIKNK ETKAKSYRIA NPVLKKSRVR
     TNSLIGWLKN LHPNDSEEKA YAQVRDIEDT VEVIALKKIS DGYGLFIENK DISQNITDPI
     IAKKVAQNTL RLPMSLSKAY NIDQTINELE RYNNSHLSQW QNSSWLKGSL GIIFDKNNEF
     ILNGFKLLYD EKYGVTIERL DKNESV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024